Invention Grant
- Patent Title: Replication competent adenoviral vectors
-
Application No.: US16756376Application Date: 2018-10-16
-
Publication No.: US11268108B2Publication Date: 2022-03-08
- Inventor: Virginia Ammendola , Stefano Colloca , Alessandra Vitelli
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/EP2018/078206 WO 20181016
- International Announcement: WO2019/076877 WO 20190425
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N7/00 ; C07K14/005 ; A61K39/00 ; A61K35/76 ; A61K9/00 ; A61K39/12
Abstract:
Replication competent simian adenoviral vectors are provided for the delivery of exogenous immunogens. Vectors of the invention demonstrate superior replication and expression of exogenous immunogens. They are useful as prophylactic and therapeutic vaccines as well as in gene therapy.
Public/Granted literature
- US20210189421A1 REPLICATION COMPETENT ADENOVIRAL VECTORS Public/Granted day:2021-06-24
Information query
IPC分类:
